The Biotech industry is up 1.4% in the last week, with Swedish Orphan Biovitrum up 3.0%. The industry has been flat over the past 12 months despite the gain this week. As for the next few years, earnings are expected to grow by 28% per annum.
Has the Swedish Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Wed, 21 May 2025 | SEK 193.6b | SEK 33.9b | SEK 1.2b | 34.5x | 161.1x | 5.7x |
Fri, 18 Apr 2025 | SEK 175.2b | SEK 33.7b | SEK 758.3m | 29x | 231.1x | 5.2x |
Sun, 16 Mar 2025 | SEK 196.7b | SEK 33.7b | SEK 579.2m | 33.2x | 339.6x | 5.8x |
Tue, 11 Feb 2025 | SEK 218.0b | SEK 33.7b | SEK 360.5m | 54.6x | 604.8x | 6.5x |
Thu, 09 Jan 2025 | SEK 219.4b | SEK 33.0b | -SEK 4,418,647,416.22 | 160.3x | -49.6x | 6.6x |
Sat, 07 Dec 2024 | SEK 214.0b | SEK 33.0b | -SEK 4,445,855,070.07 | 146.4x | -48.1x | 6.5x |
Mon, 04 Nov 2024 | SEK 215.9b | SEK 33.2b | -SEK 4,482,059,813.14 | 138.3x | -48.2x | 6.5x |
Wed, 02 Oct 2024 | SEK 210.4b | SEK 31.4b | -SEK 5,523,741,940.78 | 49.5x | -38.1x | 6.7x |
Fri, 30 Aug 2024 | SEK 212.8b | SEK 31.4b | -SEK 5,507,219,147.57 | 51x | -38.6x | 6.8x |
Sun, 28 Jul 2024 | SEK 205.1b | SEK 31.4b | -SEK 5,422,714,425.02 | 46.9x | -37.8x | 6.5x |
Tue, 25 Jun 2024 | SEK 195.4b | SEK 30.6b | -SEK 5,516,807,975.13 | 39.1x | -35.4x | 6.4x |
Thu, 23 May 2024 | SEK 190.8b | SEK 30.6b | -SEK 5,462,243,356.40 | 39.4x | -34.9x | 6.2x |
Sat, 20 Apr 2024 | SEK 177.7b | SEK 29.8b | -SEK 5,266,079,807.91 | 63.7x | -33.8x | 6x |
Mon, 18 Mar 2024 | SEK 186.1b | SEK 29.8b | -SEK 5,636,600,511.99 | 59.6x | -33x | 6.2x |
Wed, 14 Feb 2024 | SEK 173.7b | SEK 29.6b | -SEK 5,690,161,945.72 | 60.6x | -30.5x | 5.9x |
Fri, 12 Jan 2024 | SEK 187.1b | SEK 28.7b | -SEK 1,198,694,522.00 | 58.8x | -156.1x | 6.5x |
Sun, 10 Dec 2023 | SEK 169.9b | SEK 28.7b | -SEK 1,200,221,950.00 | 58.4x | -141.6x | 5.9x |
Tue, 07 Nov 2023 | SEK 157.8b | SEK 28.6b | -SEK 1,293,138,519.00 | 48.4x | -122x | 5.5x |
Thu, 05 Oct 2023 | SEK 161.2b | SEK 27.4b | -SEK 2,017,277,396.00 | 47.8x | -79.9x | 5.9x |
Sat, 02 Sep 2023 | SEK 155.3b | SEK 27.4b | -SEK 1,967,118,727.00 | 52.5x | -78.9x | 5.7x |
Mon, 31 Jul 2023 | SEK 156.0b | SEK 27.5b | -SEK 1,534,283,427.00 | 55.8x | -101.7x | 5.7x |
Wed, 28 Jun 2023 | SEK 160.4b | SEK 26.4b | -SEK 1,312,987,475.00 | 45.5x | -122.2x | 6.1x |
Fri, 26 May 2023 | SEK 171.9b | SEK 26.3b | -SEK 1,366,671,495.00 | 45.3x | -125.8x | 6.5x |
Sun, 23 Apr 2023 | SEK 173.8b | SEK 25.5b | -SEK 2,076,198,392.00 | 39.7x | -83.7x | 6.8x |
Tue, 21 Mar 2023 | SEK 164.2b | SEK 25.4b | -SEK 2,030,181,364.00 | 37.8x | -80.9x | 6.5x |
Thu, 16 Feb 2023 | SEK 176.3b | SEK 25.3b | -SEK 1,664,056,988.00 | 27x | -106x | 7x |
Sat, 14 Jan 2023 | SEK 173.3b | SEK 23.8b | -SEK 1,844,394,225.00 | 31.6x | -94x | 7.3x |
Mon, 12 Dec 2022 | SEK 157.5b | SEK 23.8b | -SEK 1,826,624,890.00 | 32.1x | -86.2x | 6.6x |
Wed, 09 Nov 2022 | SEK 151.9b | SEK 23.9b | -SEK 3,186,214,696.00 | 33x | -47.7x | 6.4x |
Fri, 07 Oct 2022 | SEK 155.4b | SEK 22.9b | -SEK 3,331,692,568.00 | 32.1x | -46.6x | 6.8x |
Sun, 04 Sep 2022 | SEK 161.0b | SEK 22.9b | -SEK 3,245,057,861.00 | 33.6x | -49.6x | 7x |
Tue, 02 Aug 2022 | SEK 173.8b | SEK 22.7b | -SEK 3,478,859,664.00 | 35.8x | -50x | 7.7x |
Thu, 30 Jun 2022 | SEK 152.3b | SEK 21.4b | -SEK 3,520,100,841.00 | 38.4x | -43.3x | 7.1x |
Sat, 28 May 2022 | SEK 157.9b | SEK 21.4b | -SEK 3,493,623,798.00 | 44.3x | -45.2x | 7.4x |
-45.2x
Which industries have driven the changes within the Swedish Healthcare industry?
SE Market | 0.62% | |
Healthcare | 1.10% | |
Biotech | 2.11% | |
Biotech | 2.11% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
SOBI Swedish Orphan Biovitrum | SEK 310.40 | 3.0% +SEK 3.1b | 11.5% | PE26.9x | |
BIOA B BioArctic | SEK 185.00 | 7.6% +SEK 1.2b | -17.0% | PS63.6x | |
CRNO B Cereno Scientific | SEK 10.75 | 18.1% +SEK 464.8m | 183.6% | PS37.4x | |
CURAS Curasight | DKK 5.40 | 157.1% +DKK 69.8m | -46.0% | PB45.6x | |
SANION Saniona | SEK 8.39 | 5.9% +SEK 64.0m | 318.5% | PE6.1x |